Results 181 to 190 of about 38,442 (298)

851 Self-Medication with Caffeine for 31 Years: A Case of Undiagnosed Childhood Narcolepsy Type II [PDF]

, 2021
Moustapha Doulaye Seydou, Christian Karime, Brenda L. Wyrick, Amir Khan   +3 more
openalex   +1 more source

Physiological significance of autocrine orexinergic signaling in extra‐hypothalamic tissues

Physiological Reports, Volume 14, Issue 8, April 2026.
Mechanisms of autocrine orexinergic effects in extra‐hypothalamic tissues. Abstract Orexin‐A and orexin‐B, originally discovered as hypothalamic neuropeptides, have been detected in extra‐hypothalamic tissues together with their receptors (OX1R and OX2R) since the early 2000s.
Jean Claude Hakizimana, Makinde Vincent Olubiyi, Abdullateef Isiaka Alagbonsi   +2 more
wiley   +1 more source

Research progress of immunologic mechanism of narcolepsy

Chinese Journal of Contemporary Neurology and Neurosurgery, 2013
Narcolepsy is a severe neurological sleep disorder, which is caused by the large loss of Hypocretin (Hcrt)/Orexin producing neurons in the hypothalamus in narcolepsy with cataplexy patients.
Hui-juan WU, Tao YANG, Yan ZHU, Yang YANG, Zhong-xin ZHAO   +4 more
doaj  

Anti-Tribbles Homolog 2 Autoantibodies in Japanese Patients with Narcolepsy [PDF]

, 2010
Hiromi Toyoda, Susumu Tanaka, Taku Miyagawa, Yutaka Honda, Katsushi Tokunaga, Makoto Honda   +5 more
openalex   +1 more source

Th17 Cell Related Cytokine Profiles in Narcolepsy and Other Types of Excessive Daytime Sleepiness

Journal of Sleep Sciences, 2016
Background and Objective: Narcolepsy is a chronic neurological disorder caused by loss of hypocretin (Hcrt) neurons. Both genetic and environmental factors play an important role for the development of narcolepsy. The mechanism of Hcrt loss in narcolepsy
Demeke G. Debebe, Khosro Sadeghniat-Haghighi, Yadollah Shakiba, Ania Rahimi Golkhandan, Maryam Izad   +4 more
doaj  

Recent advances in narcolepsy

, 2016
Paul Reading
openalex   +1 more source

Palliative Care in Europe: Safeguarding Compassion Amidst Changing End‐of‐Life Policies and Expanding Access to Medically Assisted Dying Position Statement on behalf of the European Academy of Neurology, the European Federation of Neurological Associations and OneNeurology

European Journal of Neurology, Volume 33, Issue 4, April 2026.
Katarina Rukavina, Marianne de Visser, Elena Moro, Kailash Bhatia, Paul Boon, Jana Midelfart‐Hoff, Matilde Leonardi, Irena Rektorova, Gereon R. Fink, Nathalie Nasr, Alicia Gonzalez‐Martinez, Claudio L. A. Bassetti, Ulf Kallweit, Michael Crean, Patrick Cras, Ludo Vanopdenbosch, Astri Arnesen, Joke Jaarsma, Alexander Bernhard Kowski, Simone Veronese, David Oliver, on behalf of the European Academy of Neurology, the European Federation of Neurological Associations, OneNeurology   +23 more
wiley   +1 more source

Anti-Ma2 Encephalitis as a Treatable Cause of Narcolepsy Type 1: A Case Report. [PDF]

Am J Case Rep
Wang M, Zhang N, Bian Z, Li Y, Wang S.
europepmc   +1 more source

Sleep schedules and MSLT‐based diagnosis of narcolepsy type 2 and idiopathic hypersomnia: Exploring potential associations in a large clinical sample [PDF]

Kentaro Matsui, Akira Usui, Yoichiro Takei, Kenichi Kuriyama, Yuichi Inoue   +4 more
openalex   +1 more source

Narcolepsy

Canadian Medical Association Journal
Humphreys, Christopher J., Liu, Ran R., Simms, Taryn M.   +2 more
openaire   +2 more sources